← FDA DRUG APPROVALS

FDA NDA · NDA203791

SITAVIG

Sponsor: LIGAND PHARMS

APPLICATION
NDA203791
TYPE
NDA
ORIGINAL APPROVAL
2013-04-12
LATEST ACTION
2019-12-18
ROUTE
BUCCAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SITAVIG · ReferenceDiscontinued
ACYCLOVIR 50MG · TABLET · BUCCAL

Approval history

2019-12-18Labeling · Supplement 1 · standard — Label ↗AP
2013-04-12Type 3 - New Dosage Form · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →